Claude Science Launches
Anthropic just launched Claude Science to run biology research autonomously—and they just stole a Nobel laureate from DeepMind. 🧬
What the video says
Why is DeepMind losing its grip? Nobel laureate John Jumper is leaving.
He is joining Anthropic. This defection marks a pivotal shift in laboratory automation.
Anthropic just launched Claude Science. It is a standalone flagship.
It is available now. The tool autonomously carries out biology research from simple instructions.
Its power is formidable. Opus 4.5 is highly advanced.
It performs like a graduate student. This milestone release elevates scientific AI to a core focus.
Deep-pocketed pharmaceutical companies are the target. Anthropic wants their contracts.
The strategy is clear: landing these deals represents a decisive step towards success. The financial stakes are massive.
Anthropic expects its first profitable quarter. An IPO approaches this year.
This transition represents a major milestone. The timing is perfect.
This launch is a standout move. The market is ready.
Dominating life sciences will be a material turning point for its debut.
